Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized TrialXiaotao Qu, Alexander V. Louie, Gregory S. Zaric et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 41